These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1649765)

  • 61. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
    Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract]   [Full Text] [Related]  

  • 62. Inhibition of lens opacification in x-irradiated rats treated with WR-77913.
    Osgood TB; Menard TW; Clark JI; Krohn KA
    Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1780-4. PubMed ID: 3025129
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase separation inhibitors and lens transparency.
    Clark JI; Livesey JC; Steele JE
    Optom Vis Sci; 1993 Nov; 70(11):873-9. PubMed ID: 8302522
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clearance of S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913) in rats.
    Lam TT; Liu D; Brody MA; Chu R; Tso MO
    Exp Eye Res; 1991 Jun; 52(6):661-7. PubMed ID: 1649765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetic profile of amifostine.
    Shaw LM; Bonner H; Lieberman R
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):18-22. PubMed ID: 8783662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome.
    Culy CR; Spencer CM
    Drugs; 2001; 61(5):641-84. PubMed ID: 11368288
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of radioprotective agents on X-ray cataracts.
    Reddy VN; Ikebe H; Giblin FJ; Clark JI; Livesey JC
    Lens Eye Toxic Res; 1989; 6(4):573-88. PubMed ID: 2562120
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacologic approaches to protection against radiation-induced lethality and other damage.
    Weiss JF
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1473-8. PubMed ID: 9467066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amifostine for protection from antineoplastic drug toxicity.
    Foster-Nora JA; Siden R
    Am J Health Syst Pharm; 1997 Apr; 54(7):787-800. PubMed ID: 9099346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The cytoprotective agent amifostine (WR-2721): current clinical use and trends in its development].
    Dragojević-Simić V; Dobrić S
    Vojnosanit Pregl; 1996; 53(4):305-10. PubMed ID: 9229947
    [No Abstract]   [Full Text] [Related]  

  • 71. Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine.
    Castiglione F; Dalla Mola A; Porcile G
    Tumori; 1999; 85(2):85-91. PubMed ID: 10363072
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amifostine and hematologic effects.
    Sriswasdi C; Jootar S; Giles FJ
    J Med Assoc Thai; 2000 Apr; 83(4):374-82. PubMed ID: 10808697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amifostine: the first selective-target and broad-spectrum radioprotector.
    Kouvaris JR; Kouloulias VE; Vlahos LJ
    Oncologist; 2007 Jun; 12(6):738-47. PubMed ID: 17602063
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.